EE+ POEM Archive
Liraglutide reduces mortality (NNT = 71) in patients with T2DM and very high CV risk
Liraglutide reduces mortality (NNT = 71) in patients with T2DM and very high CV risk is a topic covered in the EE+ POEM Archive.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Liraglutide Reduces Mortality (NNT = 71) in Patients With T2DM and Very High CV Risk." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314080/all/Liraglutide_reduces_mortality__NNT_=_71__in_patients_with_T2DM_and_very_high_CV_risk.
Liraglutide reduces mortality (NNT = 71) in patients with T2DM and very high CV risk. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314080/all/Liraglutide_reduces_mortality__NNT_=_71__in_patients_with_T2DM_and_very_high_CV_risk. Accessed September 27, 2022.
Liraglutide reduces mortality (NNT = 71) in patients with T2DM and very high CV risk. (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314080/all/Liraglutide_reduces_mortality__NNT_=_71__in_patients_with_T2DM_and_very_high_CV_risk
Liraglutide Reduces Mortality (NNT = 71) in Patients With T2DM and Very High CV Risk [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2022 September 27]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314080/all/Liraglutide_reduces_mortality__NNT_=_71__in_patients_with_T2DM_and_very_high_CV_risk.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Liraglutide reduces mortality (NNT = 71) in patients with T2DM and very high CV risk
ID - 1314080
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314080/all/Liraglutide_reduces_mortality__NNT_=_71__in_patients_with_T2DM_and_very_high_CV_risk
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
